AIIMS Delhi has cleared India's first indigenous mRNA cancer vaccine for a Phase-2 clinical trial.\n\nDeveloped in partnership with an Indian biotech, the personalised vaccine targets tumour-specific mutations in advanced melanoma.
SponsoredNew drop · Run the city
PUMA — Forever Faster